Jie Liu

机构：Guilin Medical University, Dazhou Central Hospital · ORCID：0009-0009-7541-9205

发表论文 13 篇 · 总被引 250 次 · h-index 8

代表论文

• miR-199a-3p is involved in the pathogenesis and progression of diabetic neuropathy through downregulation of SerpinE2 (2017 · Molecular Medicine Reports · 被引 63)
• Next Generation Sequencing Analysis of miRNAs: MiR-127-3p Inhibits Glioblastoma Proliferation and Activates TGF-β Signaling by Targeting SKI (2014 · OMICS A Journal of Integrative Biology · 被引 50)
• miR‑221‑3p and miR‑222‑3p regulate the SOCS3/STAT3 signaling pathway to downregulate the expression of NIS and reduce radiosensitivity in thyroid cancer (2021 · Experimental and Therapeutic Medicine · 被引 38)
• Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages (2025 · Hepatology · 被引 27)
• miR-143-Mediated Responses to Betaine Supplement Repress Lipogenesis and Hepatic Gluconeogenesis by Targeting MAT1a and MAPK11 (2022 · Journal of Agricultural and Food Chemistry · 被引 22)
• MicroRNA-135a Protects Against Ethanol-Induced Apoptosis in Neural Crest Cells and Craniofacial Defects in Zebrafish by Modulating the Siah1/p38/p53 Pathway (2020 · Frontiers in Cell and Developmental Biology · 被引 16)